Adapting a Parkinson's quality of life questionnaire for Turkish speakers
Turkish Adaptation, Validity and Reliability of "Parkinson's Disease Quality of Life 7 (PDQoL7)" Questionnaire
This study is trying to adapt a quality of life questionnaire for Turkish-speaking people with Parkinson's Disease to better understand their daily challenges.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 70 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Nigde Omer Halisdemir University Academic / other |
| Locations | 3 sites (Ankara and 2 other locations) |
| Trial ID | NCT06230926 on ClinicalTrials.gov |
What this trial studies
This study aims to adapt the Parkinson's Disease Quality of Life 7 (PDQoL7) questionnaire into Turkish to assess the quality of life in individuals diagnosed with Parkinson's Disease (PD). It involves evaluating the validity and reliability of the questionnaire, which consists of 7 questions addressing the difficulties faced by patients in daily activities. Data will be collected from participants at the Neurology Outpatient Clinic of Niğde Ömer Halisdemir University Training and Research Hospital, in collaboration with Gazi University. Participants must be Turkish-speaking individuals diagnosed with PD and capable of understanding the study's purpose and methodology.
Who should consider this trial
Good fit: Ideal candidates for this study are Turkish-speaking individuals diagnosed with Parkinson's Disease who can understand and respond to the questionnaire.
Not a fit: Patients with dementia, significant hearing or vision loss, or those who are illiterate may not benefit from this study.
Why it matters
Potential benefit: If successful, this adaptation could provide a reliable tool for assessing the quality of life in Turkish-speaking patients with Parkinson's Disease.
How similar studies have performed: Other studies have successfully adapted quality of life questionnaires for various populations, suggesting that this approach is both valid and beneficial.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed with PD by a neurologist, * Understands and speaks Turkish, * Individuals who score 18 points or above from the mini-mental state assessment will be included. Exclusion Criteria: * People with dementia, hearing and/or vision loss * Patients who are illiterate will be excluded from the study.
Where this trial is running
Ankara and 2 other locations
- Ankara Medipol University — Ankara, Turkey (Recruiting)
- Gazi University — Ankara, Turkey (Recruiting)
- Niğde Ömer Halisdemir University — Niğde, Turkey (Recruiting)
Study contacts
- Study coordinator: Aslı ÇELİK, MSc.
- Email: fztaslicelik@gmail.com
- Phone: +90388 311 21 05
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.